The firm is targeting the FDA’s 505(b)(2) pathway for a potentially expedited approval process. The post Silo Pharma Proceeds with Ketamine Implant for...
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development...
Filament Health (NEO: FH) is walking away from a Nasdaq listing and major financing after hitting certain roadblocks related to The post Filament Health...
Penny stocks under $3 to watch this week. The post 3 Penny Stocks Under $3 To Watch Right Now appeared first on Penny Stocks to Buy,...
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development...
White had been struggling with issues related to excessive alcohol consumption prior to visiting the Costa Rica facility The post Ron ‘Tater Salad’...
Big news as the trial met its primary endpoint, with 50% clinical remission rate at Week 4. The post MindMed Announces Positive Results from Phase 2b...
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development...
Filament Health has signed a non-binding term sheet for up to US$14.4 million in funding through a convertible note. The post Filament Health Announces...
The soon-to-issue patent contains composition of matter and methods of use claims for a family of novel prodrug derivatives of psilocybin. The post Enveric...